Bellerophon Therapeutics
Warren, US · Founded 2015
Biotech
Founders & leadership
NA
Naseem AminDirector
JL
Jens LuehringDirector
MA
Mary Ann CloydDirector
PS
Parag ShahVice President of Business Operations
MD
Martin DekkerVice President of Engineering and Manufacturing
AM
Andre MouraDirector
PF
Peter FernandesChief Regulatory and Safety Officer
JP
Jonathan PeacockChairman of the Board
SB
Scott BruderDirector
DT
Daniel TasseDirector
FT
Fabian TenenbaumChief Executive Officer and Director
DQ
Deborah QuinnChief Medical Officer
Reported raises · per SEC filings
Form D private placements$23.4MraisedOct 2017 · 11 investors · Pharmaceuticals
Rule 506(b)$1.6MraisedMay 2017 · 7 investors · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.